Metasmitesp. z o.o. in liquidation

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-03-06
Share capital
5,000.00 PLN
Registered address
ul. Bożego Miłosierdzia 4/3, 31-104 Kraków, Poland

Financials

Revenue history (in k)

Filing timeliness

2 of 3 financial statements were filed late (the longest delay 29 days for 2023).

  • 202505/05/2026
  • 202404/08/2025
  • 202313/08/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Scientific research and development1,593 / 1,952
Top 82%
Voivodeship · Małopolskie40,219 / 46,040
Top 87%
Country · Poland434,353 / 495,935
Top 88%

Results vs industry

Revenue
This companyUSD 3.08kMedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD -2.00kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 4.39kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 79.97MedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Maria Elżbieta Mycielskaage 55 – Liquidator

Ownership

OwnerSharesShare valueStake
90$1,215.5690%
Others
10$135.0610%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jun 15, 2026Call to creditors

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,159

Competitors

Name
MedappS.A.
SkinlabP.S.A.
EIT Rawmaterials Clc Eastsp. z o.o.
COS LabP.S.A.
IntelliseqS.A.
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.
Medtransfersp. z o.o.
Oncotherics PolandS.A.
Fusiomicasp. z o.o.
Ncage TherapeuticsS.A.

Change history

DateEvent
2026-06-08Name change
2026-05-20Liquidation opened
2023-09-21Address change
2023-09-21Name change
2023-03-06Entered in the register

FAQ

Last updated: 2026-06-08